This is the authors' abstract. We don't add key points for this paper.
In node-positive, ER-negative/HER2-negative BC, increasing lymphocytic infiltration was associated with excellent prognosis. Further validation of the clinical utility of tumor-infiltrating lymphocytes in this context is warranted. Our data also support the evaluation of immunotherapeutic approaches in selected BC subtypes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Loi et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: